ZINC PYRITHIONE IN COMBINATION THERAPY OF ATOPIC DERMATITIS: PATHOGENETIC SUBSTANTIATION AND RESULTS OF STUDIES
The review is devoted to the pathogenetic substantiation of the use of the activated zinc pyrithione agent in atopic dermatitis. The main mechanisms of formation of the pathological process in atopic dermatitis are explained in more details: hereditary predisposition, violations of the barrier funct...
Main Author: | |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Remedium Group LLC
2018-01-01
|
Series: | Медицинский совет |
Subjects: | |
Online Access: | https://www.med-sovet.pro/jour/article/view/2250 |
Summary: | The review is devoted to the pathogenetic substantiation of the use of the activated zinc pyrithione agent in atopic dermatitis. The main mechanisms of formation of the pathological process in atopic dermatitis are explained in more details: hereditary predisposition, violations of the barrier function of the skin and immunological dysfunction leading to the development and persistence of chronic inflammation. The role of zinc ions in the pathogenesis of atopic dermatitis is discussed. The article presents the detailed analysis of the main clinical studies of the activated zinc pyrithione agent in atopic dermatitis, its positive effect on such symptoms as itching, skin manifestations, skin microbioma and severity of the disease course. |
---|---|
ISSN: | 2079-701X 2658-5790 |